Resistance to Immunotherapy Caused by MUC4 Expression in HER2+ Tumors – Bench to Bedside

Time: 12:00 pm
day: Day Two


• Exploring how MUC4 expression predicts resistance to immunotherapy
• Targeting soluble TNF reverses resistance in animal models
• Understand how knowing the MUC4 status of a patient’s tumor will improve clinical decision making and should benefit patient outcome